Table 1.
Demographic or Clinical Characteristic | CRC Risk Subcohort |
EC Risk Subcohort |
Other Cancer Risk Subcohort |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Carriers(n = 365) |
Noncarriers(n = 903) |
Carriers(n = 215) |
Noncarriers(n = 523) |
Carriers(n = 446) |
Noncarriers(n = 1,029) |
|||||||
No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | |
MMR gene mutated | ||||||||||||
MLH1 | 134 | 37 | 87 | 41 | 161 | 36 | ||||||
MSH2 | 178 | 49 | 105 | 49 | 222 | 50 | ||||||
MSH6 | 40 | 11 | 18 | 8 | 47 | 11 | ||||||
PMS2 | 13 | 3 | 5 | 2 | 16 | 3 | ||||||
Sex | ||||||||||||
Female | 201 | 55 | 523 | 58 | 215 | 100 | 523 | 100 | 241 | 54 | 587 | 57 |
Male | 164 | 45 | 380 | 42 | — | — | 205 | 46 | 442 | 43 | ||
Race | ||||||||||||
White | 346 | 96.4 | 847 | 96.3 | 205 | 97.2 | 488 | 96 | 423 | 96.4 | 965 | 96 |
Latino/Hispanic | 1 | 0.3 | 13 | 1.5 | 1 | 0.5 | 7 | 1 | 4 | 0.9 | 17 | 2 |
Asian | 9 | 2.5 | 8 | 0.9 | 3 | 1.4 | 5 | 1 | 9 | 2.0 | 9 | 1 |
Middle Eastern | 2 | 0.6 | 5 | 0.6 | 2 | 0.9 | 4 | 1 | 2 | 0.5 | 6 | 1 |
Other | 1 | 0.3 | 7 | 0.8 | 0 | 0 | 5 | 1 | 1 | 0.2 | 7 | 1 |
Unknown | 6 | 23 | 4 | 14 | 7 | 25 | ||||||
Country of recruitment | ||||||||||||
Canada | 24 | 6 | 27 | 3 | 9 | 4 | 23 | 4 | 24 | 5 | 30 | 3 |
United States | 50 | 14 | 110 | 12 | 31 | 14 | 69 | 13 | 75 | 17 | 135 | 13 |
Australasia | 291 | 80 | 766 | 85 | 175 | 81 | 431 | 82 | 347 | 78 | 864 | 84 |
Source of ascertainment | ||||||||||||
Population based | 59 | 16 | 135 | 15 | 35 | 16 | 77 | 15 | 71 | 16 | 154 | 15 |
Clinic based | 306 | 84 | 768 | 85 | 180 | 84 | 446 | 85 | 375 | 84 | 875 | 85 |
Age at recruitment, years | ||||||||||||
Mean | 39.9 | 48.3 | 39.8 | 47.3 | 41.3 | 48.9 | ||||||
SD | 13.8 | 15.6 | 13.1 | 15.9 | 13.9 | 15.4 | ||||||
Follow-up | ||||||||||||
Total person-years | 1,809 | 4,930 | 1,061 | 2,848 | 2,365 | 5,880 | ||||||
Mean, years | 5.0 | 5.5 | 4.9 | 5.5 | 5.3 | 5.7 | ||||||
SD, years | 2.5 | 2.5 | 2.5 | 2.5 | 2.4 | 2.5 | ||||||
Median, years | 4.9 | 5.4 | 4.8 | 5.4 | 5.2 | 5.6 | ||||||
Range, years | 0.3–11.2 | 0.1–11.9 | 0.2–11.2 | 0.2–11.9 | 0.4–11.2 | 0.1–11.9 |
Abbreviations: CRC, colorectal cancer; EC, endometrial cancer; SD, standard deviation.